November 22, 2005
Genelabs Technologies to Present at the Wall Street Analyst Forum

November 9, 2005
GENELABS TECHNOLOGIES, INC. REPORTS FINANCIAL RESULTS FOR THE THIRD QUARTER AND FIRST NINE MONTHS OF 2005

November 3, 2005
Genelabs Technologies to Present at the Rodman & Renshaw Techvest 7th Annual Healthcare Conference

October 19, 2005
Genelabs Technologies to Present at the BIO InvestorForum

October 12, 2005
Genelabs Announces Approval of Application to Transfer Listing of its Common Stock from the Nasdaq National Market to the Nasdaq Capital Market

October 5, 2005
Genelabs Applies to Transfer its Listing to the Nasdaq Capital Market

October 3, 2005
Genelabs Presents Data on Two Preclinical Candidates at the 12th International Symposium on Hepatitis C and Related Viruses

September 26, 2005
Genelabs Plans to Appeal Staff Determination Letter from Nasdaq Regarding its Listing on the Nasdaq National Market

August 18, 2005
GENELABS ANNOUNCES RESULTS FROM PRELIMINARY ANALYSIS OF AN OPEN LABEL STUDY OF ITS LUPUS DRUG PRESTARA™

August 10, 2005
GENELABS REPORTS FINANCIAL RESULTS FOR THE SECOND QUARTER AND FIRST HALF OF 2005

August 4, 2005
Genelabs Drug Discovery Team Advances Compounds Against the Hepatitis C Virus In Preclinical Development

June 22, 2005
Genelabs Receives Confirmation of Orphan Drug Designation for Prestara and Provides Update on its Development

June 14, 2005
Genelabs Announces Results from Annual Shareholders Meeting

May 31, 2005
Genelabs Technologies to Present at the Wall Street Analyst Forum

May 10, 2005
GENELABS TECHNOLOGIES, INC. REPORTS FIRST QUARTER 2005 FINANCIAL RESULTS

April 27, 2005
Genelabs Technologies to Present at the Rodman & Renshaw Techvest 2nd Annual Global Healthcare Conference

April 18, 2005
GENELABS PROVIDES UPDATE ON HCV RESEARCH PROGRAMS AND COMMENTS ON PROPOSED REVERSE STOCK SPLIT

April 6, 2005
GENELABS ANNOUNCES PRELIMINARY RESULTS OF GENOVATE’S CLINICAL TRIAL GBL03-00 IN WOMEN WITH SYSTEMIC LUPUS ERYTHEMATOSUS

March 14, 2005
GENELABS TECHNOLOGIES REPORTS 2004 YEAR-END
AND FOURTH QUARTER FINANCIAL RESULTS

© Genelabs Technologies, Inc. All rights reserved. - Terms of Use